High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy
- 1 February 2000
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 118 (2) , 279-288
- https://doi.org/10.1016/s0016-5085(00)70210-1
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Clinical pattern of corticosteroid dependent Crohnʼs diseaseEuropean Journal of Gastroenterology & Hepatology, 1998
- Involvement ofMDR1 P-glycoprotein in multifactorial resistance to methotrexateInternational Journal of Cancer, 1996
- Frequency of glucocorticoid resistance and dependency in Crohn's disease.Gut, 1994
- Expression of an mdr gene is associated with a new form of resistance to dexamethasone-induced apoptosisMolecular Endocrinology, 1993
- Clinical patterns, natural history, and progression of ulcerative colitisDigestive Diseases and Sciences, 1993
- Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammalsPharmacology & Therapeutics, 1993
- Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes [see comments]Blood, 1992
- Multidrug resistance activity in human lymphocytesHuman Immunology, 1991
- A rapid and sensitive flow cytometric method for the detection of multidrug‐resistant cellsCytometry, 1989
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989